Trilaciclib (CED0010967)

Record Information

Version

1.0

Creation Date

2026-04-14 20:17:57 UTC

Update Date

2026-08-22 03:51:16 UTC

SynCED ID

CED0010967

Secondary Accession Numbers

CHEM133097

Identification

Common Name

Trilaciclib

Class

Small Molecule

Description

Trilaciclib is an organic compound with the chemical formula C24H30N8O and an average molecular weight of 446.56 g/mol. Trilaciclib belongs to the piperazines, a subclass of diazinanes within the organic compounds. This compound is associated with two recorded sources: electrical and electronic equipment, specifically electric hearing aids, and healthcare, pharmaceuticals and veterinary products, specifically unclassified therapeutic products. The recorded route of exposure for this substance is intravenous. In terms of biological activity, trilaciclib acts on six recorded protein targets. It functions as an inhibitor of cyclin-dependent kinase 2 (CDK2), cyclin-dependent kinase 4 (CDK4), cyclin-dependent kinase 6 (CDK6), and cyclin-dependent kinase 9 (CDK9), in addition to two other proteins.

Contaminant Type

Not Available

Chemical Structure

MOL SDF PDB SMILES InChI

Synonyms

Not Available

Chemical Formula

C₂₄H₃₀N₈O

Average Molecular Mass

446.559 g/mol

Monoisotopic Mass

446.254 g/mol

CAS Registry Number

1374743-00-6

IUPAC Name

Not Available

Traditional Name

Not Available

SMILES

CN1CCN(CC1)C1=CN=C(NC2=NC3=C(C=C4N3C3(CCCCC3)CNC4=O)C=N2)C=C1

InChI Identifier

InChI=1S/C24H30N8O/c1-30-9-11-31(12-10-30)18-5-6-20(25-15-18)28-23-26-14-17-13-19-22(33)27-16-24(7-3-2-4-8-24)32(19)21(17)29-23/h5-6,13-15H,2-4,7-12,16H2,1H3,(H,27,33)(H,25,26,28,29)

InChI Key

PDGKHKMBHVFCMG-UHFFFAOYSA-N

Chemical Taxonomy

Classification

Not classified

Biological Properties

Status

Detected and Not Quantified

Origin

Not Available

Cellular Locations

Not Available

Biofluid Locations

Not Available

Tissue Locations

Not Available

Applications

Not Available

Biological Roles

inhibitor (PMC13397993 )?

Chemical Roles

Not Available

Organoleptic Effects

Not Available

Physical Properties

State

Not Available

Appearance

Not Available

Experimental Properties

Property	Value
Melting Point	Not Available
Boiling Point	Not Available
Solubility	Not Available

Predicted Properties

Not Available

Spectra

Spectrum Type	Description	Splash Key	Deposition Date	View
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum	splash10-0002-0000900000-e85b813bf490945e8dd7	Not Available	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum	splash10-0002-0002900000-f692b698ed993af49d59	Not Available	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum	splash10-03di-1109400000-f7e2b1854c19eaf570fb	Not Available	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum	splash10-0002-0000900000-c1d4adc4e022a6bf5847	Not Available	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum	splash10-0002-0000900000-d001dd2edee98f8f3938	Not Available	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum	splash10-02mi-1069300000-dfaf6db6a4265e3a005b	Not Available	View Spectrum

Toxicity Profile

Toxicity Values

Toxicity Value	Organism	Dose Descriptor	Route of Exposure	Predicted or Experimental	Toxicity Rating	Reference
249.0 Log mg/kg [140:440]	Rat	LD50	oral	predicted	Not Available	Not Available

Toxicity / Toxin Class

Not Available

Mechanism of Toxicity

Not Available

Carcinogenicity (IARC Classification)

Not Available

Minimum Risk Level

Not Available

Symptoms

Not Available

Treatment

Not Available

Health Effects

Health Effect	Relationship	Direction	Description	Reference

Exposure Sources

Source ID	Source	Sector	Reference
CEDs000409	Unclassified therapeutic products?Unclassified therapeutic products encompass a range of substances used in medical and veterinary contexts that have not undergone formal classification processes.	Healthcare, pharmaceuticals & veterinary products	Not Available
CEDs000516	Electric Hearing Aids?Electric hearing aids are small electronic devices designed to amplify sound for individuals with hearing loss.	Electrical & Electronic Equipment	PubChem

Pathways

1 pathwayPathway Source: PathBank

Trilaciclib Drug Metabolism Action Pathway

Targets

Structure	Protein	UniProt ID	Organism	Relationship	Details
Click to view 3D structure	Cyclin-dependent kinase 2	P24941	Humans	Predicted (SEA)	Prediction Confidence Score 0.664 Applicability Domain 1.0 Statistical Significance 4.30e-04 Supporting Reference Compounds 1029 E-value 3.34752
Click to view 3D structure	Cyclin-dependent kinase 6	Q00534	Humans	Predicted (SEA)	Prediction Confidence Score 0.602 Applicability Domain 1.0 Statistical Significance 2.60e-04 Supporting Reference Compounds 100 E-value 2.02408
Click to view 3D structure	Cyclin-dependent kinase 4	P11802	Humans	Predicted (SEA)	Prediction Confidence Score 0.48 Applicability Domain 0.833 Statistical Significance 0.002 Supporting Reference Compounds 233 E-value 15.8034
Click to view 3D structure	Receptor-type tyrosine-protein kinase FLT3	P36888	Humans	Predicted (SEA)	Prediction Confidence Score 0.471 Applicability Domain 0.833 Statistical Significance 0.0137 Supporting Reference Compounds 1274 E-value 106.576
Click to view 3D structure	Serine/threonine-protein kinase Nek10	Q6ZWH5	Humans	Predicted (SEA)	Prediction Confidence Score 0.454 Applicability Domain 0.833 Statistical Significance 1.00e-05 Supporting Reference Compounds 2 E-value 0.0778492
Click to view 3D structure	Cyclin-dependent kinase 9	P50750	Humans	Predicted (SEA)	Prediction Confidence Score 0.453 Applicability Domain 0.833 Statistical Significance 0.003 Supporting Reference Compounds 426 E-value 23.3548
Click to view 3D structure	NUAK family SNF1-like kinase 2	Q9H093	Humans	Predicted (SEA)	Prediction Confidence Score 0.421 Applicability Domain 0.833 Statistical Significance 0.0016 Supporting Reference Compounds 108 E-value 12.6116
Click to view 3D structure	Dual specificity protein kinase TTK	P33981	Humans	Predicted (SEA)	Prediction Confidence Score 0.399 Applicability Domain 0.833 Statistical Significance 0.0049 Supporting Reference Compounds 171 E-value 38.4575
Click to view 3D structure	Serine/threonine-protein kinase ULK2	Q8IYT8	Humans	Predicted (SEA)	Prediction Confidence Score 0.377 Applicability Domain 0.833 Statistical Significance 0.0025 Supporting Reference Compounds 91 E-value 19.618
Click to view 3D structure	Proto-oncogene tyrosine-protein kinase Src	P12931	Humans	Predicted (SEA)	Prediction Confidence Score 0.368 Applicability Domain 0.395 Statistical Significance 0.0408 Supporting Reference Compounds 1158 E-value 317.781
Click to view 3D structure	Fibroblast growth factor receptor 1	P11362	Humans	Predicted (SEA)	Prediction Confidence Score 0.362 Applicability Domain 0.398 Statistical Significance 0.0372 Supporting Reference Compounds 1010 E-value 289.833
Click to view 3D structure	Cytochrome P450 3A4	P08684	Humans	Predicted (SEA)	Prediction Confidence Score 0.361 Applicability Domain 0.407 Statistical Significance 0.0434 Supporting Reference Compounds 1538 E-value 338.255
Click to view 3D structure	Serine/threonine-protein kinase PAK 4	O96013	Humans	Predicted (SEA)	Prediction Confidence Score 0.352 Applicability Domain 0.397 Statistical Significance 0.0293 Supporting Reference Compounds 728 E-value 228.41
Click to view 3D structure	Aurora kinase A	O14965	Humans	Predicted (SEA)	Prediction Confidence Score 0.35 Applicability Domain 0.39 Statistical Significance 0.0448 Supporting Reference Compounds 996 E-value 348.842
Click to view 3D structure	Cyclin-dependent kinase 1	P06493	Humans	Predicted (SEA)	Prediction Confidence Score 0.345 Applicability Domain 0.39 Statistical Significance 0.0307 Supporting Reference Compounds 715 E-value 238.919
Click to view 3D structure	Insulin receptor	P06213	Humans	Predicted (SEA)	Prediction Confidence Score 0.344 Applicability Domain 0.39 Statistical Significance 0.0384 Supporting Reference Compounds 772 E-value 298.863
Click to view 3D structure	Cyclin-dependent kinase 7	P50613	Humans	Predicted (SEA)	Prediction Confidence Score 0.343 Applicability Domain 0.39 Statistical Significance 0.0234 Supporting Reference Compounds 406 E-value 182.089
Click to view 3D structure	Proto-oncogene tyrosine-protein kinase receptor Ret	P07949	Humans	Predicted (SEA)	Prediction Confidence Score 0.342 Applicability Domain 0.398 Statistical Significance 0.0459 Supporting Reference Compounds 764 E-value 357.094
Click to view 3D structure	Platelet-derived growth factor receptor beta	P09619	Humans	Predicted (SEA)	Prediction Confidence Score 0.341 Applicability Domain 0.398 Statistical Significance 0.0361 Supporting Reference Compounds 597 E-value 281.347
Click to view 3D structure	Macrophage colony-stimulating factor 1 receptor	P07333	Humans	Predicted (SEA)	Prediction Confidence Score 0.34 Applicability Domain 0.398 Statistical Significance 0.0467 Supporting Reference Compounds 833 E-value 363.4
Click to view 3D structure	Tyrosine-protein kinase JAK2	O60674	Humans	Predicted (SEA)	Prediction Confidence Score 0.339 Applicability Domain 0.375 Statistical Significance 0.0602 Supporting Reference Compounds 1022 E-value 469.042
Click to view 3D structure	Tyrosine-protein kinase ABL1	P00519	Humans	Predicted (SEA)	Prediction Confidence Score 0.338 Applicability Domain 0.398 Statistical Significance 0.0526 Supporting Reference Compounds 927 E-value 409.487
Click to view 3D structure	MAP/microtubule affinity-regulating kinase 3	P27448	Humans	Predicted (SEA)	Prediction Confidence Score 0.338 Applicability Domain 0.398 Statistical Significance 0.0351 Supporting Reference Compounds 627 E-value 273.329
Click to view 3D structure	Activated CDC42 kinase 1	Q07912	Humans	Predicted (SEA)	Prediction Confidence Score 0.337 Applicability Domain 0.375 Statistical Significance 0.0253 Supporting Reference Compounds 331 E-value 197.348
Click to view 3D structure	Epidermal growth factor receptor	P00533	Humans	Predicted (SEA)	Prediction Confidence Score 0.335 Applicability Domain 0.375 Statistical Significance 0.0704 Supporting Reference Compounds 1301 E-value 547.981